Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents

Journal of Pediatric Gastroenterology and Nutrition

Volumn 64, Issue 3, 2017, Pages 413-417

  Famouri, Fatemeh ^a   Shariat, Zainab ^a   Hashemipour, Mahin ^a   Keikha, Mojtaba ^a   Kelishadi, Roya ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adolescents; Children; Nonalcoholic Fatty Liver Disease; Obesity; Probiotics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADOLESCENT; ADOLESCENT OBESITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BODY MASS; BODY WEIGHT; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HEPATOGRAPHY; HUMAN; IRAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIPLE BLIND PROCEDURE; WAIST CIRCUMFERENCE; BIFIDOBACTERIUM; BLOOD; COMPLICATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; TREATMENT OUTCOME;

ADOLESCENT; BIFIDOBACTERIUM; BIOMARKERS; CHILD; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; PROBIOTICS; TREATMENT OUTCOME;

EID: 84991481613     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001422     Document Type: Article

References (29)

1. Chalasani N, Younossi Z, Lavine JE, et al., American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterology. The diagnosis and management of non-Alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-609.
2. Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010;105:2093-102.
3. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: A review and update. Dig Dis Sci 2010;55:560-78.
4. Mencin AA, Lavine JE. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 2011;14:151-7.
5. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-93.
6. Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of nonalcoholic fatty liver disease. Dig Dis 2010;28:155-61.
7. Nobili V, Alkhouri N, Alisi A, et al. Nonalcoholic fatty liver disease: A challenge for pediatricians. JAMA Pediatr 2015;169:170-6.
8. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718-23.
9. Park JS, Seo JH, Youn HS. Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease. Pediatr Gastroenterol Hepatol Nutr 2013;16:22-7.
10. Iacono A, Raso GM, Canani RB, et al. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J NutrBiochem 2011;22:699-711.
11. Yang M, Gong S, Ye SQ, et al. Non-Alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 2014;6:4691-705.
12. Ferolla SM, Armiliato GN, Couto CA, et al. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol 2015;7:559-65.
13. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000;314:1-27.
14. Wilson SR, Withers CE. The liver. In: Rumack CM, Wilson SR, Charbone-Au JW, eds. Diagnostic Ultrasound. 3rd ed. California: Elsevier Mosby; 2005:95-6.
15. Goodman E, Daniels SR, Morrison JA, et al. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-51.
16. Adibi A, Kelishadi R, Beihaghi A, et al. Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan. Endokrynol Pol 2009;60:14-9.
17. Wilson SR, Withers CE. Abdominal, pelvic, and thoracic sonography. Diagnostic ultrasound. Romac Text Book of Radiology. 4th ed. Laurel, MD: American Institute of Ultrasound in Medicine; 2011.
18. Vajro P, Lenta S, Pignata C, et al. Therapeutic options in pediatric nonalcoholic fatty liver disease: current status and future directions. Ital J Pediatr 2012;38:55.
19. Kelishadi R, Farajian S, Mirlohi M. Probiotics as a novel treatment for non-Alcoholic fatty liver disease; a systematic review on the current evidences. Hepat Mon 2013;13:e7233.
20. Vajro P, Mandato C, Licenziati MR, et al. Effects of Lactobacillus rhamnosus strain GG in pediatricobesity-related liver disease. J Pediatr Gastroenterol Nutr 2011;52:40-3.
21. Alisi A, Bedogni G, Baviera G, et al. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-Alcoholic steatohepatitis. Aliment Pharmacol Ther 2014;39:1276-85.
22. Malaguarnera M, Vacante M, Antic T, et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholicsteatohepatitis. Dig Dis Sci 2012;57:545-53.
23. Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005;39:540-3.
24. Eslamparast T, Poustchi H, Zamani F, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: A randomized, doubleblind, placebo-controlled pilot study. Am J ClinNutr 2014;99: 535-42.
25. Aller R, De Luis DA, Izaola O, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 2011;15:1090-5.
26. Wong VW, Won GL, Chim AM, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 2013;12:256-62.
27. De Rodas BZ, Gilliland SE, Maxwell CV. Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 andcalcium in swine with hypercholesterolemia induced by diet. J Dairy Sci 1996;79:2121-8.
28. Usman A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemicrats. J Dairy Sci 2000;83:1705-11.
29. Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 2002;37:259-81.